Huang TT, Brill E, Nair JR, Zhang X, et al. Targeting the PI3K/mTOR pathway augments CHK1 inhibitor-induced replication stress and antitumor activity in high-grade serous ovarian cance. Cancer Res 2020 Sep 30. pii: 0008-5472.CAN-20-1439.
PMID: 32998994